ASHG 2026 · Tools, software & services

R&D Systems at ASHG 2026

Austin, Texas

R&D Systems at ASHG 2026 in Montréal: Booth 1524.

1524
exhibit booth

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
R&D Systems
Austin, Texas
Public company~3,000 people
Bio-Techne Diagnostics sells molecular diagnostic kits, quality controls, and IVD reagents. It serves clinical laboratories, assay developers, and diagnostic manufacturers.
Agreed to be acquired by Merck KGaA for $73 per share, a deal folding it into a larger life-science conglomerate.
Agreed to be acquired by Merck KGaA for $73 per share, a deal folding it into a larger life-science conglomerate.
2026-06 · source
Partnered with Refeyn on an integrated workflow for characterizing bispecific antibodies and biosimilars, a new offering for biologics developers.
2026-06 · source
Reorganized its products under three brands, including a new standalone Bio-Techne Diagnostics brand, clarifying how customers navigate its diagnostics line.
2026-04 · source
Source: company newsroom
Q4 FY2026 revenue $321.2M, up 1% reported
Organic growth was 3%; the pending Merck KGaA acquisition may affect future reporting. · 2026-08-12
“Net sales for the fourth quarter increased 1% to $321.2 million. Organic growth increased 3% compared to the prior year.”
Source: results release
Currently hiring
Source: careers page
Booth
Exhibiting at Booth 1524
Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting R&D Systems in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction